GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AUM-601 | AUM601 | CHC 2014 | CHC2014 | Chemical Compound 50 [US20160168156A1] [1] | HL 5101 | HL5101 | NOV 1601 | NOV-1601
Compound class:
Synthetic organic
Comment: We mapped the structure for the INN boditrectinib via PubChem to research code AUM601, which is a selective, orally bioavailable pan-tropomyosin related kinase (TRK; a.k.a., neurotrophin tyrosine receptor kinase, NTRK) inhibitor [1]. It inhbits wild-type NTRKs and variants with resistance mutations. AUM601 is an oncology clinical lead that's being developed by AUM Biosciences. Previous research codes include CHC2014 and NOV1601.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (E)-3-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-1-piperazin-1-ylprop-2-en-1-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12591 | boditrectinib |
Synonyms ![]() |
|
| AUM-601 | AUM601 | CHC 2014 | CHC2014 | Chemical Compound 50 [US20160168156A1] [1] | HL 5101 | HL5101 | NOV 1601 | NOV-1601 | |
Database Links ![]() |
|
| CAS Registry No. | 1940165-80-9 (source: WHO INN record) |
| GtoPdb PubChem SID | 479821159 |
| PubChem CID | 121395201 |
| Search Google for chemical match using the InChIKey | BQFYCHBYISNPFW-SQZHUTIHSA-N |
| Search Google for chemicals with the same backbone | BQFYCHBYISNPFW |
| Search PubMed clinical trials | boditrectinib |
| Search PubMed titles | boditrectinib |
| Search PubMed titles/abstracts | boditrectinib |
| UniChem Compound Search for chemical match using the InChIKey | BQFYCHBYISNPFW-SQZHUTIHSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | BQFYCHBYISNPFW-SQZHUTIHSA-N |